SomaGenics Awarded $1.8M NIH Grant to Develop Real-Seq Platform | GenomeWeb

NEW YORK (GenomeWeb) – SomaGenics has been awarded a two-year, $1.8 million Phase II Small Business Innovation Research grant from the National Institutes of Health to further develop its Real-Seq platform for next-generation sequencing of small RNAs.

The award will allow the firm to further refine its RealSeq-AC library construction approach, including streamlining workflow, increasing yield, and broadening utility to include RNA species such as tRNAs, fragments of mRNAs, and long noncoding RNAs, the firm said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.

Feb
23
Sponsored by
NuGEN

This webinar will discuss a project that sought to understand the parent-of-origin epigenetic mechanisms that regulate seed development in plants, with a particular emphasis on differentiating the maternal or paternal origin of epigenetics marks.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.